Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cellular and humoral response after MRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients
David Cucchiari, Natalia Egri, Marta Bodro, et al.
American Journal of Transplantation (2021) Vol. 21, Iss. 8, pp. 2727-2739
Open Access | Times Cited: 226

Showing 1-25 of 226 citing articles:

Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review
Simon Galmiche, Liêm Binh Luong Nguyen, Éric Tartour, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 2, pp. 163-177
Open Access | Times Cited: 175
Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking Era
Mounzer Agha, Maggie Blake, Charles Chilleo, et al.
Open Forum Infectious Diseases (2021) Vol. 8, Iss. 7
Open Access | Times Cited: 147
Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector-based COVID-19 vaccine regimens in solid organ transplant recipients
Tina Schmidt, Verena Klemis, David Schub, et al.
American Journal of Transplantation (2021) Vol. 21, Iss. 12, pp. 3990-4002
Open Access | Times Cited: 142
Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals
Katlyn Lederer, Emily Bettini, Kalpana Parvathaneni, et al.
Cell (2022) Vol. 185, Iss. 6, pp. 1008-1024.e15
Open Access | Times Cited: 138
Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR T-cell therapy
Binod Dhakal, Sameem Abedin, Timothy S. Fenske, et al.
Blood (2021) Vol. 138, Iss. 14, pp. 1278-1281
Open Access | Times Cited: 124
Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients
José Jesús Broseta, Diana Rodríguez‐Espinosa, Néstor Rodríguez, et al.
American Journal of Kidney Diseases (2021) Vol. 78, Iss. 4, pp. 571-581
Open Access | Times Cited: 112
Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients With CKD
Edward J Carr, Andreas Kronbichler, Matthew Graham‐Brown, et al.
Kidney International Reports (2021) Vol. 6, Iss. 9, pp. 2292-2304
Open Access | Times Cited: 107
Immunogenicity and Risk Factors Associated With Poor Humoral Immune Response of SARS-CoV-2 Vaccines in Recipients of Solid Organ Transplant
Kasama Manothummetha, Nipat Chuleerarux, Anawin Sanguankeo, et al.
JAMA Network Open (2022) Vol. 5, Iss. 4, pp. e226822-e226822
Open Access | Times Cited: 87
Vaccination in patients with kidney failure: lessons from COVID-19
Nina Babel, Christian Hugo, Timm H. Westhoff
Nature Reviews Nephrology (2022) Vol. 18, Iss. 11, pp. 708-723
Open Access | Times Cited: 79
The Global Impact of COVID-19 on Solid Organ Transplantation: Two Years Into a Pandemic
Ailish Nimmo, Dale Gardiner, Ines Ushiro‐Lumb, et al.
Transplantation (2022) Vol. 106, Iss. 7, pp. 1312-1329
Open Access | Times Cited: 76
Cellular and humoral immune response after mRNA-1273 SARS-CoV-2 vaccine in liver and heart transplant recipients
Sabina Herrera, Jordi Colmenero, Mariona Pascal, et al.
American Journal of Transplantation (2021) Vol. 21, Iss. 12, pp. 3971-3979
Open Access | Times Cited: 93
Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept
Nathalie Chavarot, Antoine Morel, Marianne Leruez‐Ville, et al.
American Journal of Transplantation (2021) Vol. 21, Iss. 12, pp. 4043-4051
Open Access | Times Cited: 93
Safety and cross-variant immunogenicity of a three-dose COVID-19 mRNA vaccine regimen in kidney transplant recipients
Filippo Massa, Marion Crémoni, Alexandre O. Gérard, et al.
EBioMedicine (2021) Vol. 73, pp. 103679-103679
Open Access | Times Cited: 76
Antibody Responses to Natural SARS-CoV-2 Infection or after COVID-19 Vaccination
Haya Altawalah
Vaccines (2021) Vol. 9, Iss. 8, pp. 910-910
Open Access | Times Cited: 69
Poor Antibody Response After Two Doses of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine in Transplant Recipients
Alessandra Mazzola, Ève Todesco, S. Drouin, et al.
Clinical Infectious Diseases (2021) Vol. 74, Iss. 6, pp. 1093-1096
Open Access | Times Cited: 66
A ‘mix and match’ approach to SARS-CoV-2 vaccination
Meagan E. Deming, Kirsten E. Lyke
Nature Medicine (2021) Vol. 27, Iss. 9, pp. 1510-1511
Closed Access | Times Cited: 66
Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipients
Maria Prendecki, Tina Thomson, Candice Clarke, et al.
The Lancet (2021) Vol. 398, Iss. 10310, pp. 1482-1484
Open Access | Times Cited: 65
A third injection of the BNT162b2 mRNA COVID-19 vaccine in kidney transplant recipients improves the humoral immune response
Christophe Masset, Clarisse Kerleau, Claire Garandeau, et al.
Kidney International (2021) Vol. 100, Iss. 5, pp. 1132-1135
Open Access | Times Cited: 61
Humoral and Cellular Vaccination Responses against SARS-CoV-2 in Hematopoietic Stem Cell Transplant Recipients
Monika Lindemann, Vesna Klisanin, Laura Thümmler, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1075-1075
Open Access | Times Cited: 60
Immunogenicity of COVID-19 vaccines in solid organ transplant recipients: a systematic review and meta-analysis
Xinpei Chen, De Luo, Bingjie Mei, et al.
Clinical Microbiology and Infection (2022) Vol. 29, Iss. 4, pp. 441-456
Open Access | Times Cited: 44
Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses
Jeffrey Tomalka, Mehul S. Suthar, Steven G. Deeks, et al.
Nature Immunology (2022) Vol. 23, Iss. 3, pp. 360-370
Open Access | Times Cited: 38
Rapid, scalable assessment of SARS-CoV-2 cellular immunity by whole-blood PCR
Megan Schwarz, Denis Torre, Daniel Lozano‐Ojalvo, et al.
Nature Biotechnology (2022) Vol. 40, Iss. 11, pp. 1680-1689
Open Access | Times Cited: 38
Decline in Antibody Concentration 6 Months After Two Doses of SARS-CoV-2 BNT162b2 Vaccine in Solid Organ Transplant Recipients and Healthy Controls
Sebastian Rask Hamm, Dina Leth Møller, Laura Pérez‐Alós, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 37
Recombinant neutralizing secretory IgA antibodies for preventing mucosal acquisition and transmission of SARS-CoV-2
Kathrin Göritzer, Elisabetta Groppelli, Clemens Grünwald‐Gruber, et al.
Molecular Therapy (2024) Vol. 32, Iss. 3, pp. 689-703
Open Access | Times Cited: 11
Negative immune responses to two-dose mRNA COVID-19 vaccines in renal allograft recipients assessed with simple antibody and interferon gamma release assay cellular monitoring
Marta Crespo, Antoni Barrilado-Jackson, Eduardo Padilla, et al.
American Journal of Transplantation (2021) Vol. 22, Iss. 3, pp. 786-800
Open Access | Times Cited: 46
Page 1 - Next Page

Scroll to top